Publications
2024
Effectiveness of tildrakizumab for itch, pain, and fatigue in patients with moderate-to-severe psoriasis: 52-week results from the real-world POSITIVE study
Effectiveness of tildrakizumab in patients with moderate-to-severe psoriasis located in special areas: 52-week results from the POSITIVE study
Assessing Quality of Life in Children with Dermatological Conditions – Validation of the InToDermQoL Questionnaire
Vitiligo - a disease: A position paper on stigmatization, life quality impairment and psychosocial comorbidity
PMID:
DOI:
Patient needs in women of childbearing age with psoriasis: retrospective analysis from the German PsoBest registry
DOI:
Breaking Barriers: Randomized Controlled Trials Assessing an Intervention to Combat Stigma in Chronic Skin Disease
Personal, Financial and Time Burden in Inherited Ichthyoses: A Survey of 144 Patients in a University-based Setting
PMID:
DOI:
Unterdiagnostiziert und unterbehandelt
Reducing self-stigma in chronic skin disease - Development and pilot-test of the HautKompass online programme
Impact of patient psoriasis on partner well-being in a real-world setting: 52-week interim data of the phase IV POSITIVE study
Thank you for your response
I am...